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http://www.biomedcentral.com/1472-6882/13/211RESEARCH ARTICLE Open AccessThe anti-shigellosis activity of the methanol
extract of Picralima nitida on Shigella dysenteriae
type I induced diarrhoea in rats
Laure Brigitte Mabeku Kouitcheu1*, Joseph Lebel Tamesse2 and Jacques Kouam3Abstract
Background: Picralima nitida Stapf (Apocynaceae) is a medicinal plant used traditionally in Cameroon to cure
various ailments such as gastrointestinal disorders and dysentery. This study reports the in vitro and in vivo
anti-shigellosis activity of the methanol extract of this plant on rats.
Methods: The antimicrobial activity of the extract against pathogenic strains was evaluated using the disc diffusion
assay and broth microdilution method. After oral administration of a suspension of Shigella dysenteriae type I (sd1),
diarrheic rats were divided into 5 groups; the control group received the vehicle of the extract and the four others
125, 250, 500 mg/kg of the plant extract and ciprofloxacin (20 mg/kg) respectively for 7 days. The frequency of
faeces emission as well as the weight of normal and diarrheic faeces was recorded. The presence of stools
containing mucus or blood and the number of sd1 in faeces were also recorded.
Results: In vitro, the extract had an antimicrobial effect on 11 out of the 17 pathogenic strains tested. The values of
CMI and CMB obtain against Shigella dysenteriae type I were 800 and 6400 μg/ml respectively. In vivo, diarrhoea
induction was effective and we notice an increase in faeces frequency and weight (p < 0.05), increase in the
percentage of diarrheic stool released as well as the mucus contained in stool (p < 0.05), an increase in bacterial
population in stool (p < 0.05). Picralima nitida extract, like ciprofloxacin markedly reduces the frequency faeces
released and sd1 density from 100% (diarrheic rats) to 47.22 and 61.69% (500 mg/kg) respectively. It also slowed
down the movement of charcoal meal through gastro-intestinal tract with the percentage of intestinal length
covered of 60.54 (500 mg/kg).
Conclusion: This anti-shigellosis activity in vitro and in vivo attests the usefulness of Picralima nitida in the
traditional treatment of gastrointestinal disorders such as dysentery.
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Shigellosis is an infectious disease caused by various spe-
cies of Shigella: S. boydii, S. dysenteriae, S. flexneri, and S.
sonnei. Out of these, S. dysenteriae is found worldwide and
concentrated in areas where the population bear the brunt
of overcrowding and malnutrition and do not possess ad-
equate waste management and safe drinking water supplies
[1]. Shigellosis is associated with 5-15% of cases of diar-
rhoea and 30-50% of cases of dysentery worldwide [2]. In* Correspondence: lauremabek@yahoo.fr
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reproduction in any medium, provided the ormalnourished children, shigellosis can cause a vicious cycle
of further impaired nutrition absorption, recurrent infec-
tion, and growth retardation [3]. Without proper care,
shigellosis can progress to the life-threatening systemic dis-
ease called hemolytic uremic syndrome, which is character-
ized by thrombocytopenia, hemolytic uremia, and kidney
failure [4]. About 3% of persons who are infected with
S. flexneri may subsequently develop pains in their joints,
irritation of the eyes, and painful urination [5,6]. This con-
dition called Reiter's syndrome can lead to chronic arthritis
which is difficult to treat.
Shigellosis can usually be treated with antibiotics. An-
tibiotics commonly used are ampicillin, trimethoprim/ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ciprofloxacin. Some Shigella have become resistant to
antibiotics and inappropriate use of antibiotics to treat
shigellosis can make the organisms more resistant in
the future. Resistance to quinolone antibiotics has been
reported for S. dysenteriae type I (sd1) which rapidly de-
velops resistance to the current therapy [7,8]. Dominant
clone of ciprofloxacin–resistant sd1 was observed in
Southeast Asia and in Canada [9,10]. This situation
leads scientists to search for new sources of antimicro-
bial substances from various sources like medicinal
plants [11,12].
Picralima nitida Stapf (PN) (Apocynaceae) is an entirely
glabrous shrub of 3–10 m high, found in African forest re-
gion, spanning from Ivory Coast to Zaire and Uganda
[13]. Medicinally, the plant is used in the treatment of
malaria, male sexual impotence, dysmenorrhoea, gastro-
intestinal disorders and dysentery [13]. It has been shown
to possess anti-trypanosomiac, anti-inflammatory, anti-
pyretic and anti-plasmodial properties [14-17]. It has also
been shown to possess an activity against Castor oil-
induced diarrhea [18]. But the use of this medicinal plant
as treatment against gastrointestinal infection as well as
against dysentery is based simply on traditional beliefs per-
petuated along several generations. The evaluation of the
antidysenteric activity in vitro and in vivo of this medicinal
plant will offer the best opportunity to understand its ra-
tional use in ethno-medicine.
This study reports the antimicrobial properties of
methanol (M) extract of PN fruit-rinds against 17
pathogenic species involved in gastrointestinal infection
isolated from patients as well as the evaluation of its
anti-dysenteric activity as well as activity on gastrointes-
tinal transit in rat model.
Methods
Plant material
The fruit of PN were collected in the morning in Zo-Et
élé, Cameroon in September 2011. The identification of
the plant was confirmed at the National Herbarium in
Yaoundé-Cameroon (reference number of the plant: N°
2136/SRFK). The seeds of the fruits of PN were removed
and the fruit-rinds were kept. The plant material (fruit-
rinds of PN) was then air dried at room temperature.
The dried plant material was ground into a fine powder.
Chemicals and culture media
Mueller Hinton agar and salmonella-shigella agar were
purchased from Oxoid, Basingstoke, England; Sabouraud
dextrose agar from Merck SA, Sao Paulo, Brazil and
Peptone water from HiMedia, Mumbai, India. Anti-
microbial susceptibility testing was performed by the
disc diffusion method with commercially available disks
(Biomerieux F 69260 Charbonnières, France) for Cefoxitin(30 μg), Dibekacine (10 μg) and Clindamycin (10 μg);
(Becton, Dickinson and Company Sparks, USA) for
Ampicilin (10 μg), Colistin (10 μg), Nitrofurantoine (100
μg), Streptomycin (10 μg), Kanamycin (30 μg), Spectino-
mycin (25 μg) and Tobramycin (2 μg); (Oxoid, Basingstore,
England) for Doxycyclin monohydrate (30 μg), Netilmicin
(30 μg), Erythromicin (15 μg), Amoxycillin/Clavulanique
(20/10 μg), Amoxicillin (10 μg), Gentamicin (10 μg),
Vancomycin (30 μg); (Himedia, Mumbai, India) of cipro-
floxacin (5 μg). Gentamicin (Gentamycin injection, 8 mg/
2ml, ZMC Hamburg GMBH German), Nystatin (500000
UI, Novadina Pharmaceutical Ltd, London, United King-
dom) and Ciprofloxacin (ZOFLOX, ciprofloxacine 750 mg,
Odypharm) used as reference antibiotics for the determin-
ation of the MIC and MBC as well as for the in vivo test
were purchased from local pharmacy.
Extraction
This was carried out by soaking the dried powdered plant
(250 g) in bottle with 3.5 l of methanol (M) and kept for
72 h. The plant-(M) mixture was then sieved. The filtrate
(extract) was concentrated by evaporating under vacuum
(M) using a rotating evaporator. The extract was further
concentrated by allowing it to stand overnight in an oven
at 30°C. The yield of the extraction was calculated by div-
iding the weight of the extract obtained by the weight of
the dried material plant extracted.
Phytochemical screening
Preliminary analysis of chemical constituents such as alka-
loids, leucoanthocyanins, flavonoids, saponins, tannins,
anthraquinones, polyphenols, coumarins, sterols and/or
triterpenes, anthocyanins, cardiac glycosides, reducing
sugars, glycosides, anthranoids and steroids was carried
out. Those constituents were identified by characteristic
colour changes using standard procedures previously de-
scribed [19]. Each test was qualitatively expressed as nega-
tive (−) or positive (+) and the intensity of the characteristic
colour was expressed as (++) or (+++).
Test for alkaloids (Meyer reagent)
Fifty milligrams of the tested compound was heated in
10 ml of 2% H2SO4 for 2 min and filtered. To 1 ml of the
filtrate, a few drops of the Meyer Reagent was added. The
presence of alkaloids was indicated by the obtaining of a
white precipitation or turbidity.Test of flavonoides
Fifty milligrams of the tested compound was introduced
in 5 ml of methanol. To it was added some magnesium
chip and concentrated hydrochloric acid drop wise. The
presence of flavonoids was indicated by the appearance of
a violet or brick red coloration with effervescence.
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Fifty milligrams of the tested compound was dissolved
in 10 ml distilled water. To 0.5 ml of this mixture was
added 2 ml of 2N HCl and heated in a water bath at
100°C. The presence of leucoanthocyanines was indi-
cated by the appearance of red coloration which later
changes to violet.
Test for saponins
Fifty milligrams of the tested compound was added to 5
ml of distilled water. After homogenization, the mixture
was boiled in 5 min, cooled and filtrated. 5 ml of the fil-
trate was vigorously agitated for 10 to 30 s. The presence
of saponins was indicated by the appearance of foam
which persists within 15 min.
Test for tanins
Fifty milligrams of the tested compound was added in 5
ml of distiller water. After mixing, the mixture was
boiled for 5 min, cooled and filtrated. 5 ml of 2% NaCl
was added to 10 ml of the filtrate and then filtered. The
presence of tannins was indicated by the formation of a
precipitate after the addition of 1% gelatin to the filtrate.
Test of anthraquinones
Fifty milligrams of the tested compound was diluted in 2
ml of chloroform, homogenized and filtered. Next, 1 ml of
10% NaOH was added to 1 ml of the filtrate. The presence
of anthraquinone was indicated by the appearance of a red
coloration.
Test of phenols and polyphenols
Fifty milligrams of the tested compound was dissolved
in 15 ml distilled water, headed in a water bath for 15
min then cooled and filtered. To 2 ml of the filtrate was
added drop wise 1 ml of 1% FeCl3 and 1 ml of 1% K3Fe
(CN)6. The presence of polyphenols and phenols was in-
dicated by the apparition of a blue and green precipitate
respectively.
Tests of coumarines
On a thin layer chromatographic plate was deposited a
spot of the tested compound dissolved in methanol.
Next, the plate was exposed to ammoniac vapors. The
presence of coumarines was indicated by the appearance
of spot whose color varied from blue to purple in the
presence of ammoniac.Test of triterpenes and sterols (Liebermann- burchard test)
Fifty milligrams of the tested compound was dissolved
in 2 ml of chloroform and next some drops of acetic an-
hydride added to the mixture and 1 ml of concentrated
H2SO4. The presence of triterpenes was revealed by theapparition of violet-red coloration and sterols by a blue
greenish coloration.
Test for anthocyanins
To 50 mg of the tested compound was added 15 ml of a
concentrated HCl, the mixture was boiled. The presence
of anthocyanins was indicated by the variation of color-
ation from orange red to orange blue during boiling.
Test for cardiotonic glycosides
In a test tube, 50 mg of the tested compound was
dissolved in 2 ml of chloroform. 2 ml of the concen-
trated H2SO4 was introduced through the walls of the
tube. Two phases were formed. The presence of cardio-
tonic glycosides was indicated by the observation of a
brown ring at the interphase.
Test of reducing sugars
Fifty milligrams of the tested compound was dissolved in
10 ml of distilled water, mixed and filtered. In a conical
flask containing 4 ml of a Fehling A and B (v/v) liquid
mixture, was introduced drop wise of the filtrate. The mix-
ture was boiled; the presence of reducing sugar was indi-
cated by the appearance of a brick red coloration.
Test of glycosides
Fifty milligrams of the tested compound was added to
5 ml of 5% HCl then neutralized with 5 ml 5% NaOH.
After homogenization, the mixture was filtered and
Fehling liquid test was realized on the filtrate.
Test for anthranoides
Fifty milligrams of the tested compound was added to
2 ml of 0.5 KOH, then 0.5 ml of 5% H2O2 and boiled for
2 min. After cooling, the mixture was filtered. 6 drops of
concentrated acetic acid and 3 ml of toluene added to
the filtrate. The upper phase (toluene) was transferred to
a test tube in which was added 1 ml of 0.5 N KOH. The
presence of antranoides was indicated by the appearance
of red coloration in the aqueous layer.
Test of steroids
Fifty milligrams of the tested compound was dissolved in
3 ml of chloroform, agitated intermittently for 2 hours and
filtered. 1 ml of the filtrate was deposited on a porcelain
plate. After evaporation, a drop of sulfuric acid was added,
stirred and the color noted. To another portion of the fil-
trate was added a drop of acetic anhydride and the color
noted. The reaction was positive if the same color was
obtained for both sulfuric acid and acetic anhydride.
Animals
Four weeks old Wistar albino rats (weighing 65–95 g) of
both sexes were obtained from the animal house of the
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the Institute of Medical Research and Medicinal Plant
Studies (IMPM), Yaoundé. The rats were given food and
water ad libitum. These animals were used for the anti-
microbial drug assessment and the study of intestinal
transit. Animal housing and the bioassay was conducted
in accordance with the internationally accepted principle
guidelines of the European Union on Animal Care (CEE
Council 86/609). The Cameroon National Ethical Com-
mittee approved the protocols of the study (Ref n° FW-
IRB 00001954).
Microorganisms
The clinical microorganisms included here for the anti-
microbial activity screening were the most common
strains implicated in gastro-intestinal disorder such as
diarrhea and dysentery. There were 15 bacterial and 2
yeast stains : Escherichia coli LMP0101U (E. coli), Klebsi-
ella pneumoniae LMP0210U (K. pneumoniae), Shigella
dysenteriae type 1 LMP0504G (S. dysenteriae), Shigella
flexneri LMP0313U (S. flexneri), Morganella morganii
LMP0904G (M. morganii), Proteus vulgaris LMP0103U (P.
vulgaris), Proteus mirabilis LMP0504G (P. mirabilis), Sal-
monella typhi LMP0209U (S. typhi), Citrobacter freundii
LMP0804G (C. freundii), Enterobacter cloacae LMP1104G
(E. cloacae), Enterobacter agglomerans LMP1004G (E.
agglomerans), Staphylococcus aureus LMP0206U (S. aur-
eus), Streptococcus feacalis LMP0207U (S. feacalis), Pseudo-
monas aeruginosa LMP0102U (P. aeruginosa), Bacillus
cereus T F 3748 (B. cereus T), Candida albicans LMP0204-
U (C. albicans) and Candida glabrata LMP0205U (C.
glabrata). These microorganisms were obtained from Bac-
teriology and Mycology Laboratories of Centre Pasteur of
Yaoundé-Cameroon and Bacillus cereus T was obtained
from the Microbiology Laboratory of the Institute of Food
Research Reading of Great Britain.
In vitro antimicrobial activity
Disc diffusion assay
The dried plant-extract was dissolved in the same solv-
ent of extraction (M) to a final concentration of 125 mg/
ml. Sterile paper disc (6 mm of diameter) prepared from
Whatman number one filter paper were impregnated
with 10 μl of the crude extract of the plant as described
by Edward [20] from a stock of 125 mg/ml. Each disc
contains 1.25 mg of the extract. These paper discs were
kept in an incubator at 37°C for 24 h to evaporate the
solvent. Antimicrobial tests were then carried out by disc
diffusion method [21]. 100 μl of the suspension of the
tested microorganism (0.5 Mc Farland standard turbid-
ity) containing 108 CFU/ml of bacterial, 106 CFU/ml of
yeast prepared from an overnight Mueller Hinton agar
culture for bacterial and Sabouraud dextrose agar for
yeast was used to seed each prepared and dried MuellerHinton agar plate for bacteria and Sabouraud dextrose
agar for yeast. The discs were arranged and firmly pressed
on the agar surface of each seeded plate. These plates,
after staying at 4°C for 2 h were incubated aerobically at
37°C for 24 h for bacteria and at 25°C for 24 h for yeast.
Similarly, paper discs containing concentration of standard
antibiotics (Gentamicin and Nystatin) were prepared and
used for the susceptibility test. Negative control was also
prepared using the same solvent employed to dissolve the
plant extract. Antimicrobial activity was evaluated by mea-
sured the zone of inhibition against the tested microorgan-
ism and were expressed by – (negative), + (zone of
inhibition ≤ 8 mm in diameter), ++ (zone of inhibition >
8 mm and ≤ 20 mm in diameter) and +++ (zone of inhib-
ition > 20 mm in diameter). The result recorded for each
bioassay was the average of 3 tests.
Only for S. dysenteriae type 1, a concentration de-
pendent effect of the extract was evaluated using disc dif-
fusion method described above. The reason of this choice
was that the strain will later be used to induce bacillary
dysentery. The concentrations of the extract tested were 5,
2.5, 1.25 and 0.625 mg. In order to determine their multi-
drug resistance profiles, antimicrobial susceptibility testing
was performed also against Sd1 by the same method
with commercially available disks of Gentamycin 10 μg,
Amoxicyclin/clavulanic Acid 20/10 μg, Nitrofurantoin 100
μg, Kanamycin 30 μg, Ampicilin 10 μg, Netilmicin 30 μg,
Colistin 10 μg, Erythromycin 15 μg, Ciprofloxacin 5 μg,
Amoxycylin 10 μg, Vancomycin 30 μg, Doxycyclin mono-
hydrate 30 μg, Spectinomycin 25 μg, Tobramycin 2 μg,
Clindamycin 10 μg, Dibekacin 10 μg, Steptomycin 10 μg
and Cefoxitin 30 μg.
Determination of MIC and MBC
Minimum inhibitory concentration (MIC) and minimum
bactericidal concentration (MBC) were assessed for the
microorganisms that were determined as sensitive to (M)
extract of PN in disc diffusion assay using the broth
microdilution method [22]. The test was performed in
peptone water supplemented with glucose 1% (w/v) with
red phenol as a colour indicator (PPG1%). Bacterial strains
were cultured overnight at 37°C in Muller Hinton and
yeast strains at 25°C in Sabouraud dextrose agar. Test
strains were suspended in normal saline (NaCl 9‰), ad-
justed to 0.5 Mc Farland standard turbidity and suspended
in PPG1% to give a final density of 5×105 CFU/ml. For the
susceptibility test, the 96-well round bottom sterile plates
were prepared by dispensing 180 μl of each inoculated
broth into wells. A 20 μl aliquot of the plant extract was
added. The concentration of extract used to evaluate
the antimicrobial activity was included from 0.39 to 12800
μg/ml. One well was considered as growth control since
no extract solution was added. The final volume of each
well was 200 μl. The content of each well was mixed and


















(−): Absence of chemical compound (+): Presence of chemical compound.
(+)< (++) < (+++): Base on the intensity of characteristic colour.
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37°C for 24 h (for bacterial strains) and at 25°C for 24 h
(for yeasts strains).
The bacterial and yeasts growth was indicated by the
colour change of the well content from the red to yellow.
The MIC was defined as the lowest concentration of the
extract to inhibit the growth of microorganism. MBC were
determined by platting 5 μl sample from red wells on
Mueller Hinton agar or on Sabouraud dextrose agar with-
out extract. The MBC was the concentration at which
there was not microbial growth. The extract tested in this
study was screened three times against each microorgan-
ism. Gentamicin for bacteria strains and Nystatin for yeast
strains at the concentration range of 0.019 to 320 μg/ml
was prepared in (PPG1%) and used as standard drugs for
the positive control. The susceptibility of the sd1 to anti-
biotic Ciprofloxacin which shown the great activity against
sd1 in disc diffusion assay was also performed by liquid di-
lution method and served as positive control.Table 2 Antimicrobial activity of the (M) extract of PN (fruit-r
assay (1.25 mg of the extract/disc)
Microorganisms M.m E.c S.a P.V C.f S.f S.d
PN -M – ++ ++ +++ – – ++
Gentamicin ++ ++ +++ +++ ++ ++ ++ +
Nystatin NT NT NT NT NT NT NT
M.m: M.morganii; E.c: E coli; S.a: S.aureus; P.V: P.vulgaris; C.f: C.freundii; S.f: S.flexneri; S
aeruginosa; P.m: P.mirabilis; S.t: S.typhi; K.p: K.pneumoniae; B.c: B.cereus; C.a: C.albican
(++): Zone of inhibition > 8 mm and ≤ 20 mm in diameter. (+++): Zone of inhibitionIn vivo antimicrobial activity
Thirty rats were individually kept in metabolic cage dur-
ing a period of observation of 7 days before diarrheal in-
duction. Diarrhoea was induced in rats using sd1 strains.
The turbidity of the sd1 inoculum was matched spectro-
photometrically at 450 nm to 4 McFarland standards.
After verifying that the rats were not sd1 carriers, they were
orally administrated with 1 ml of the saline diluted inocu-
lum. Diarrheic rats were randomly divided into 5 groups,
each containing six animals. When diarrhoea appeared, ani-
mal were administrated the anti-diarrheic drugs daily by
the oral route for 7 consecutive days: The first group (diar-
rheic control) received the vehicle of the extract (0.5%
Tween 80 in distilled water); the second group received the
antibiotic ciprofloxacin (20 mg/kg of body weight (bw) and
the remaining three groups were given orally 125, 250, and
500 mg/kg bw of M extract of PN.
Animals were observed daily for behavioural changes
and mortality patterns once before induction, during in-
duction and up to 7 days after induction. The stools of
each animal were also collected daily using a white cloth
fixed under the bars supporting the animal in the meta-
bolic cage during all the experiment period. Then, the fre-
quency and weight of normal and diarrheic faeces were
recorded. The presence of stools containing mucus or
blood was also noted daily at each experimental period.
Enumeration of sd1 in faeces was performed before diar-
rheal induction to make sure that the rats are not sd1 car-
riers, after the appearance of diarrhoea and once every day
during the 7 days of treatment. For this purpose, 0.5 mg of
faeces was homogenized in 4.5 ml of sterile saline; serial of
dilution were made and 50 μl of each dilution was seeded
over salmonella-shigella agar. After 24 h of incubation at
37°C, the number of CFU was determined.
Study of small intestinal transit
This was done according to the method proposed by
Mujumdar [23] using charcoal meal as a diet marker. The
rats were divided into 4 groups of 6 animals each. The first
group (the control group) was orally administered the ve-
hicle. The second and third groups orally received M ex-
tract of PN, 250 mg/kg and 500 mg/kg bw respectively.
The fourth group also orally received the standard drug,inds) against microorganisms tested using Disc diffusion
E.c E.a S.fe P.a P.m S.t K.p B.c C.a C.g
++ – ++ ++ ++ ++ – ++ ++ –
++ ++ ++ +++ +++ ++ ++ ++ NT NT
NT NT NT NT NT NT NT NT ++ ++
.d: S.dysenteriae; E. c: E.cloacae; E.a: E.agglomerans; S.fe: S.feacalis; P.a: P.
s; C.g: C.glabrata. NT: Not tested. (+): Zone of inhibition ≤ 8 mm in diameter.
> 20 mm in diameter. (−): Negative.
Table 3 The MIC and MBC values of the (M) extract of PN (fruit-rinds) against the microorganisms tested using
microdilution assay
Microorganisms P.a S.fe En.c S.d P.v E.c B.c S.a S.t P.m C.g C.a
MIC (μg/ml) 50 200 >12800 800 0. 78 3.12 200 3.12 100 100 25 >12800
MBC(μg/ml) 1600 1600 >12800 6400 1.56 12.5 800 12.5 400 400 200 >12800
Values are the mean of three independent determination; the variation was less than 1/100 000. E.c: E coli; S.a: S.aureus; P.V: P.vulgaris; S.d: S.dysenteriae; En. c: E.
cloacae; S.fe: S.feacalis; P.a: P.aeruginosa; P.m: P.mirabilis; S.t: S.typhi; B.c: B.cereus; C.a: C.albicans; C.g: C.glabrata. MIC: minimal inhibition concentration (μg/ml).
MBC: minimal bactericidal concentration (μg/ml).
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tion, each animal was given 1 ml of charcoal meal orally
(10% activated charcoal in 5% gum acacia). Also, 30 min
after this administration, each animal was sacrificed and
the distance covered by the charcoal meal in the intestine,
from the pylorus to the caecum was measured and
expressed as a percentage of distance moved.
Statistical analysis
The results are expressed as means ± standard deviation.
Bacterial densities were expressed in log10 before analysis.
Data were statistically evaluated using the analysis of vari-
ance following by the paired t-student’s test. The differences
between groups were considered significant at p < 0.05.Result
Phytochemical screening
The yield of the extraction was 5% w/w. Phytochemically
analysis revealed the presence of alkaloids, flavonoids,
saponins, polyphenols, cardiac glycosides and glycosides
in which alkaloids, and polyphenols were major com-
pounds (Table 1).
In vitro antimicrobial activity
The antimicrobial activity of the fruit-rinds of PN ex-
tracts against microorganisms examined in the present
study and their potency were qualitatively and quantita-
tively assessed by the presence or absence of inhibition
zone and zone diameter, MIC and MBC values. The re-
sults are given in the Tables 2 and 3.
The (M) extract of PN had antibacterial effect on 11 out
of 17 rats involved in either diarrhea, dysentery or other
gastrointestinal disorders (Table 2). The antimicrobial ef-
fect of this extract was found to be comparable to that of
the conventional antibacterial (Gentamycin) and antifun-
gal (Nystatin) drug used in this study. Maximal inhibition
zone values for the microorganisms sensitive to the (M)Table 4 Antimicrobial susceptibility test performed with com
Antibiotics G A/C Ni K A N
Diameters of the inhibitory zones (mm) 18 0 14 0 0 28
Gentamycin (G), Amoxicyclin/ clavulanic Acid (A/C), Nitrofurantoin (Ni), Kanamycin (
Amoxycylin (A), Vancomycin (V), Doxycyclin monohydrate (Dm), Spectinomycin (S),extract of PN was 21.83 mm against the Gram-negative
bacterium P. vulgaris (Table 2).
Considering that in this study crude extract was em-
ployed, the MIC values of 8 mg/ml or below against any
microorganism tested was considered as active. The best
MIC and MBC values for the microorganisms tested were
0.78 and 1.525 μg/ml respectively (Table 3). The greater
and remarkable antimicrobial activity of the extract was
recorded with P. vulgaris. Antimicrobial activity of the ex-
tract of PN was least observed with C. albicans and E. clo-
acae, the two fungal strains used.
A concentration dependent effect of the extract against
sd1 was observed with agar diffusion method. The inhib-
ition diameter began at 0.625 mg (Ø= 8.33 mm) and in-
crease progressively up to 24.5 mm for 5 mg. The result
of the antimicrobial susceptibility test performed with
commercially available discs has revealed that sd1 strain
included here was resistant to Kanamycin, Tobramycin,
Clindamycin, Amoxicyclin/Clavulanic acid, Amoxycylin,
Cefoxitin and Ampicilin (Table 4). The highest strain
sensitivity was obtained with Ciprofloxacin and was con-
firmed by data from literature [24]. The values of CMI
and CMB obtained were 800 and 6400 and 0.07 and
0.312 μg/ml for PN and Ciprofloxacin respectively.
In vivo antimicrobial activity
Animal behaviour, stool quality and mortality
The animals showed behavioural changes 3 hours after the
administration of the inoculum. The changes which lasted
2 to 3 days of treatment, included lethargy, disorientation,
seizures. The first diarrheic stool was emitted within 24
hours after the induction. Diarrheic stools were either soft
or liquid, containing mucus and smooth and very often
mucus-linked. During the 7 days of treatment, no death
was observed, except in the groups of animal receiving the
vehicle and the dose of 125 mg of the extract where 83.33
and 50% of deaths were respectively registered at the end
of the experimental period (Table 5).mercially available disks using Disc diffusion assay
C E C A V Dm S T C D S Ce
14 12 24 0 18 12 12 0 0 18 18 0
K), Ampicilin (A), Netilmicin (N), Colistin (C), Erythromycin (E), Ciprofloxacin (C),
Tobramycin (T), Clindamycin (C), Dibekacin (D), Steptomycin (S) Cefoxitin (Ce).
Table 5 Effect of the treatment on the mortality of













1 0 0 0 0 0
2 0 0 0 0 0
3 0 0 0 0 0
4 1 0 0 0 0
5 1 0 1 0 0
6 1 0 1 0 0
7 2 0 1 0 0
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In the stools of diarrheic control rats, sd1 density in-
creased significantly from the first day after induction to
the last day of the treatment compared with the initial
value administered. Compared with the diarrheic control
and the initial value administered, the antibiotic ciproflox-
acin significantly reduced the density of sd1 in the stool
from the first to the last day of the treatment. Similar to
ciprofloxacin, PN inhibited the bacterial growth in a dose
depended manner. PN extract at the dose 125 mg/kg
inhibited bacterial growth by the 3rd day but maintaining
the sd1 density at a level slightly inferior to the value ad-
ministered. The extract at the dose of 250 and 500 mg/kg
effectively reduced sd1 density from the 3rd day of therapy
and beyond; the percentage of reduction of sd1 density




















Figure 1 Shigella dysenteriae type I density in stool (log10UFC/g) over
and ciprofloxacin (Ciprof). Each data column represents the mean ± S.E.M
significantly different compared with diarrheic control (* p < 0.05; **p < 0.0Frequency and mass of normal and abnormal stool
The study shows that standard drug and the extract
markedly reduced the frequency of faeces released from
100% (diarrheic rats) to 47.22 and 79.16 (125 mg/kg) to
48.61% (250 and 500 mg/kg) respectively. From the 2nd
day of the treatment, the total faeces frequency, while in-
creasing in control diarrheic rats, decreased in all the
treated rats. This reduction was significant from the 3rd
day in rats receiving standard drug, 250 and 500 mg/kg
of the extract. The average weight of defecate in the con-
trol group at the end of the treatment was 3.58 g. Treat-
ment with each dose of the medicinal plant extract
significantly reduced the weight of the defecation to
41.35 (125 mg/kg) - 49.35% (500 mg/kg) compared with
control group (Figures 2 and 3).
The rats that did not receive the medicinal plant extract
or standard drug showed typical symptoms of shigellosis
along with watery, frequent defecation and frequent
mucous stools. The percentage of diarrheic and mucus
contained in stools of the survival animal in the control
group were respectively 95.238 and 61.90% at the end of
the treatment. Treatment with each dose of the medi-
cinal plant extract significantly reduced the percentage
of diarrheic stools to 38.88 (125 mg/kg) – 0.00% (500
mg/kg) compared with control group. Like diarrheic
stool, mucus contained in stool also reduced with the
treatment. The percentage of mucus contained in stool
were 1.00 (125 mg/kg) to 0.00% (250 and 500 mg/kg) at
the end of the treatment (Tables 6 and 7).
Effect of PN-M on charcoal-induced gut in transit changes
The administration of PN-M also slowed down the move-
ment of charcoal meal through gastro-intestinal tract









7 days of treatment with methanol extract of Picrilima nitida (PN)












































Figure 2 Total stool frequency before and during treatment of Shigella dysenteriae type I diarrheic rats with methanol extract of
Picrilima nitida (PN) and ciprofloxacin (Ciprof). Each data column represents the mean ± S.E.M. (n = 6). Data column of the same day with
superscript * are significantly different compared with diarrheic control (* p < 0.05; **p < 0.01).
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http://www.biomedcentral.com/1472-6882/13/211intestinal length covered by charcoal meal in PN-M pre-
treated (250 and 500 mg/kg) and castor oil-treated rats
was 58.27, 60.54 and 74.57 respectively. Atropine on its
part, produced a marked decrease in the propulsive move-
ment and the intestinal length covered by charcoal meal


























Figure 3 Total stool weight before and during treatment of Shigella d
nitida (PN) and ciprofloxacin (Ciprof). Each data column represents the m
are significantly different compared with diarrheic control (* p < 0.05; **p <Discussion
The (M) extract of PN fruit-rinds showed a promising
broad spectrum antibacterial property, inhibiting 80%
of bacterial strains tested, especially P. vulgaris, E. coli and
S. aureus with MBC ranging between 0.78 and 1.56 μg/ml.

















ysenteriae type I diarrheic rats with methanol extract of Picrilima
ean ± S.E.M. (n = 6). Data column of the same day with superscript *
0.01).
Table 6 Effect of the treatment on the percentage (%) of
diarrheic stool of shigella dysenteriae type 1 diarrheic rats
Days j0 j1 j2 j3 j4 j5 j6 j7
Vehicle 0 5.55 25.40 32.79 56.60 72.00 80.95 95.23
PN (125 mg/kg) 0 4 10.34 19.05 20.00 23.26 26.09 38.88
PN (250 mg/kg) 0 2.24 4.35 3.85 0 0 1.22 0
PN (500 mg/kg) 0 3.57 2.32 1.75 0 0 0 0
Ciprof (20 mg/kg) 0 3.70 1.75 0 0 0 0 0
Table 8 Effect of PN-M on charcoal-induced gut
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http://www.biomedcentral.com/1472-6882/13/211in this extract as shown in Table 1 may explain some of
its antimicrobial action since antimicrobial action of
most of these phytochemical substances has been dem-
onstrated [25-28]. These results are interesting since
these microorganisms are commonly involved in acute
diarrhoea diseases. Our data confirm previous results
about antimicrobial activity of this plant. It has been
shown that other parts (seed, root and stem bark) of
Picralima nitida has significant antimicrobial activity
[29,30]. To the best of our knowledge, this is the first
time that the antimicrobial activity of the fruit-rind of
this plant is reported.
The extract shows a concentration dependent effect
against sd1. This inhibiting activity of the extract against
sd1 was also confirmed by the sd1 count in stools, where
the decrease of bacterial population was observed by the
3rd and 5th day of treatment with both extract and stand-
ard antibiotic used. Ciprofloxacin is a bactericidal syn-
thetic antibiotic belonging to fluoroquinolone family. It
has been recognized to have a great activity against sd1.
Our data confirms this assertion since the great sensitivity
of sd1 was observed with ciprofloxacin on the 18 standard
antibiotics used. It acts by inhibiting the activity of DNA
gyrase and thereby preventing the supercoiling of the bac-
terial chromosome [31]. Consequently, the bacterial can
no longer pack its DNA into the cell.
S. dysenteriae causes dysentery by invading the co-
lonic mucosa. Following host epithelial cell invasion
and penetration of the colonic mucosa, Shigella infec-
tion is characterized by degeneration of the epithelium
and inflammation of the lamina propria. This results
in desquamation and ulceration of the mucosa, andTable 7 Effect of the treatment on the percentage (%) of
mucus contains stool of shigella dysenteriae type 1
diarrheic rats
Days j0 j1 j2 j3 j4 j5 j6 j7
Vehicle 0 14.76 19.05 16.39 22.64 48.00 57.14 61.90
PN (125 mg/kg) 0 4.00 6.90 13.04 12.22 14.82 9.302 2.32
PN (250 mg/kg) 0 2.32 0 0 0 0 1.04 0
PN (500 mg/kg) 0 3.57 0 0 0 0 0 0
Ciprof (20 mg/kg) 0 0 0 0 0 0 0 0subsequent leakage of blood, inflammatory elements
and mucus into the intestinal lumen [1]. Patients suffer-
ing from Shigella infection will therefore pass frequent,
scanty, dysenteric stool mixed with blood and mucus,
since, under these conditions, the absorption of water
by the colon is inhibited. Many diarrheic rats showed
typical symptoms of shigellosis, along with watery,
frequent defecation and frequent mucoid stools. Abnor-
malities of the central nervous system including leth-
argy, disorientation, seizures and paralysis were also
observed within those animals. The multiplication of
sd1 within colonic epithelial cells, causing cell death,
and spreading laterally to infect and kill adjacent epithe-
lial cells was suspected to being responsible for those
typical signs that occurred within 2 days after induction.
In addition, the signs of neurotoxicity and deaths observed
within diarrheic animals may be due to shiga-toxin since it
has been documented [32]. Symptoms of shigellosis in rats
reduced significantly with both Ciprofloxacin and extract
treatment with respect to the reduction of sd1 density in
stool. This result confirms the antimicrobial activity of the
extract in vitro and vivo.
PN-M significantly reduced intestinal transit as ob-
served by the decrease in intestinal motility of charcoal
meal. Probably extract increased the reabsorption of
water thereby decreasing intestinal motility as ob-
served by the decrease in intestinal transit of charcoal
meal. The delay in faecal emptying by the extract al-
lows more time for fluid absorption and subsequently
reduces fluid loss in the stool. Decrease in intestinal
transit induce by the extract could have lead to an in-
crease of enteroinvasive infections, but this might have
been prevented by the antimicrobial properties of the
extract. Earlier studies have shown that anti-dysenteric
and anti-diarrhoeal properties of medicinal plants were
found to be due to tannins, alkaloids, saponins, flavo-
noids, sterol and/or triterpenes and reducing sugars
[33,34]. Thus, alkaloids, saponins and flavonoids con-








Vehicle 74.57 ± 9.90 0
Atropine sulphate (5 mg/kg) 40.32 ± 4.25** 45.93
PN (250 mg/kg) 58.27 ± 11.20* 21.86
PN (500 mg/kg) 60.54 ± 8.17* 18.81
Data are means ± standard deviation (n = 6 per group). Values in the same
column with superscript * are significantly different compared with control
group (* p < 0.05; **p < 0.01).
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S. dysenteria type 1 strain was resistant to all antibi-
otics from the beta-lactam family used in this study.
The great sensibility of the strain was obtained with
ciprofloxacin, a synthetic antibiotic belonging to fluo-
roquinolone family. The (M) extract of PN had anti-
microbial activity on 11 out of 17 microorganisms
tested amongst witch S. dysenteriae type 1. The values
of CMI and CMB obtain against this strain were 800
and 6400 μg/ml respectively. This anti-Shigella activity
of PN was also shown in vivo. The administration of
PN extract to diarrheic rats significantly reduced the
bacterial population in stools; thereby reduce the
symptoms of shigellosis on rats.
At present, our group is concerned with the fraction-
ation and the isolation of pure compounds of the crude
extracts and the elucidation of their structures in order
to better evaluate their pharmacological activity in vitro
and in vivo.
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